Filing Details
- Accession Number:
- 0001209191-14-072738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-03 16:15:44
- Reporting Period:
- 2014-12-01
- Filing Date:
- 2014-12-03
- Accepted Time:
- 2014-12-03 16:15:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1503802 | Karyopharm Therapeutics Inc. | KPTI | Pharmaceutical Preparations (2834) | 263931704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588389 | Raza Mansoor Mirza | C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-01 | 1,535 | $0.03 | 9,262 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-01 | 5,000 | $41.86 | 4,262 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-12-02 | 5,000 | $0.03 | 9,262 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-02 | 5,000 | $45.18 | 4,262 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2014-12-01 | 1,535 | $0.00 | 1,535 | $0.03 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2014-12-02 | 5,000 | $0.00 | 5,000 | $0.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,555 | 2020-11-04 | No | 4 | M | Direct | |
| 2,555 | 2020-11-04 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.55 to $42.18, inclusive. The reporting person undertakes to provide to Karyopharm Therapeutics Inc., any security holder of Karyopharm Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.44, inclusive. The reporting person undertakes to provide to Karyopharm Therapeutics Inc., any security holder of Karyopharm Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The option, representing a right to purchase a total of 9,090 shares, vested as to 25% of the shares on November 5, 2011, and the remaining 75% of the shares vested in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
